Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Axonics Modulation Technologies Inc
0I3Current price
63.5 EUR
0 EUR (0.00%)
Last closed
70.45 USD
Company
www.axonics.com
ISIN
US05465P1012
Sector
Healthcare
Industry
Medical Devices
Exchange
Frankfurt Exchange
Capitalization
3 599 109 888 USD
Yield for 12 month
+26.04 %
1Y
3Y
5Y
10Y
15Y
0I3
Axonics, Inc., a medical technology company, engages in the development and commercialization of novel products for the treatment of bladder and bowel dysfunction. Its sacral neuromodulation (SNM) systems are used to treat patients with overactive bladder (OAB), including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence (FI) and non-obstructive urinary retention (UR); and rechargeable (R20) and recharge-free (F15) implantable SNM systems that delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of OAB, UR, and FI. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products through a direct sales force and distributors in the United States, the United Kingdom, Germany, the Netherlands, Nordic countries, and internationally. The company was formerly known as Axonics Modulation Technologies, Inc. and changed its name to Axonics, Inc. in March 2021. Axonics, Inc. was incorporated in 2012 and is based in Irvine, California. Address: 26 Technology Drive, Irvine, CA, United States, 92618
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
71.73 USDP/E ratio
–Dividend Yield
–Current Year
+366 379 000 USD
Last Year
+273 702 000 USD
Current Quarter
+116 193 000 USD
Last Quarter
+114 565 000 USD
Current Year
+265 490 000 USD
Last Year
+197 665 000 USD
Current Quarter
+89 651 000 USD
Last Quarter
+86 896 000 USD
Key Figures 0I3
1 year
3 years
5 years
10 years
EBITDA
5 273 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-0.63 %
PEG Ratio
–
Return On Equity TTM
-0.89 %
Wall Street Target Price
71.73 USD
Revenue TTM
431 902 016 USD
Book Value
13 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
24.8 %
Dividend Yield
–
Gross Profit TTM
197 665 000 USD
Earnings per share
-0.1 USD
Diluted Eps TTM
-0.1 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
844.8 %
Profit Margin
-1.31 %
Dividend Analytics 0I3
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 0I3
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation 0I3
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
163.9344
Enterprise Value Revenue
7.6091
Price Sales TTM
8.3332
Enterprise Value EBITDA
377.7897
Price Book MRQ
5.4164
Financials 0I3
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 0I3
For 52 weeks
54 USD
70.75 USD
50 Day MA
69.7 USD
Shares Short Prior Month
3 604 781
200 Day MA
68.31 USD
Short Ratio
6.08
Shares Short
3 138 776
Short Percent
6.93 %
BeatStart